Back

Platform-Imprinted Transcriptional and Clonal Remodeling of αβ and γδT Cells After Allogeneic Transplantation

Stuut, A. H. G.; Brazda, P.; Janssen, A.; Vyborova, A.; Karaiskaki, F.; Keramati, F.; de Bont, D. A.; Nicolasen, M. J. T.; Gatti, L.; Hutten, T. J. A.; Yildiz, J.; Spierings, E. T.; Straetemans, T. C. M.; Beringer, D.; Pagliuca, S.; Stunnenberg, H. G.; Sebestyen, Z.; Drylewicz, J.; de Witte, M. A.; Kuball, J. H. E.

2026-02-10 immunology
10.64898/2026.02.09.704768 bioRxiv
Show abstract

Immune reconstitution after allogeneic hematopoietic stem cell transplantation is influenced by graft-composition and viral reactivation, but the combined long-term impact on {beta} and {gamma}{delta}T cells remains unclear. We analyzed a cohort of 213 patients receiving either {beta}T cell-depleted grafts (n=146; graft engineering that removes donor {beta}T cells) or T cell-replete grafts (n=67; containing donor T cells). Longitudinal immune phenotyping was integrated with bulk and single-cell TCR repertoire and transcriptomic profiling. CMV reactivation was associated with expansion of CD8+ {beta}T cells across both transplant types and with numerical dominance of V{delta}2- {gamma}{delta}T cells specifically in {beta}T cell-depleted recipients. V{delta}2- {gamma}{delta}T cells underwent early polyclonal expansion followed by repertoire focusing, independent of CMV, whereas {beta}T cells remained clonally restricted. Reduced early V{delta}2+ {gamma}{delta}TCR diversity was associated with EBV reactivation. Single-cell and TCR tracking analyses revealed long-term persistence of donor-derived V{delta}2+ {gamma}{delta}TCRs, whereas V{delta}1+ {gamma}{delta} and {beta}T cell repertoires were predominantly rebuilt de novo. Despite de novo rebuilding, {beta}TCR repertoire diversity diverged by platform at one year: {beta}T cell-depleted recipients exhibited marked (hyper)expansion of {beta}TCR clonotypes and lower diversity than T cell-replete recipients, indicating a durable imprint of graft engineering on {beta}TCR-clonality. Transcriptomic profiling showed that post-transplant T cells predominantly adopted effector programs, with platform-dependent polarization toward cytotoxic signatures in {beta}T cell-depleted recipients and toward AREG-associated tissue-repair signatures in T cell-replete recipients, consistent with wound-healing functions. In conclusion, transplantation platforms imprint durable clonal and transcriptional remodeling of {beta} and {gamma}{delta}T cells, while viral reactivation primarily amplifies expansion without fundamentally reshaping repertoire architecture. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/704768v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@88f136org.highwire.dtl.DTLVardef@944f13org.highwire.dtl.DTLVardef@d3835corg.highwire.dtl.DTLVardef@5548ef_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 26%
6.9%
2
Cell Reports
1338 papers in training set
Top 7%
6.4%
3
eLife
5422 papers in training set
Top 17%
4.9%
4
American Journal of Transplantation
15 papers in training set
Top 0.1%
4.9%
5
Stem Cell Reports
118 papers in training set
Top 0.2%
4.3%
6
Frontiers in Immunology
586 papers in training set
Top 2%
4.0%
7
Nature Immunology
71 papers in training set
Top 0.5%
4.0%
8
Journal of Experimental Medicine
106 papers in training set
Top 0.8%
3.7%
9
JCI Insight
241 papers in training set
Top 1%
3.6%
10
Transplantation
13 papers in training set
Top 0.1%
3.6%
11
Blood
67 papers in training set
Top 0.5%
3.6%
12
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.1%
2.5%
50% of probability mass above
13
PLOS Biology
408 papers in training set
Top 8%
1.8%
14
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.7%
15
Science Advances
1098 papers in training set
Top 17%
1.7%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 32%
1.7%
17
Cell Reports Medicine
140 papers in training set
Top 4%
1.5%
18
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.7%
1.5%
19
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.3%
1.3%
20
Immunity
58 papers in training set
Top 3%
1.2%
21
Cytotherapy
14 papers in training set
Top 0.2%
1.2%
22
Blood Advances
54 papers in training set
Top 0.9%
1.2%
23
iScience
1063 papers in training set
Top 23%
1.1%
24
Molecular Therapy
71 papers in training set
Top 2%
1.1%
25
Science Immunology
81 papers in training set
Top 1%
1.0%
26
Immunology & Cell Biology
11 papers in training set
Top 0.1%
1.0%
27
Cellular & Molecular Immunology
14 papers in training set
Top 1%
1.0%
28
Circulation
66 papers in training set
Top 2%
1.0%
29
Haematologica
24 papers in training set
Top 0.4%
1.0%
30
PLOS Pathogens
721 papers in training set
Top 8%
0.9%